0001731415-25-000002.txt : 20251119 0001731415-25-000002.hdr.sgml : 20251119 20251119114856 ACCESSION NUMBER: 0001731415-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20251119 DATE AS OF CHANGE: 20251119 EFFECTIVENESS DATE: 20251119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Keenan Capital Fund, LP CENTRAL INDEX KEY: 0001731415 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-306213 FILM NUMBER: 251497617 BUSINESS ADDRESS: STREET 1: 1229 BURLINGAME AVENUE STREET 2: SUITE 201 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6503443332 MAIL ADDRESS: STREET 1: 1229 BURLINGAME AVENUE STREET 2: SUITE 201 CITY: BURLINGAME STATE: CA ZIP: 94010 D/A 1 primary_doc.xml X0708 D/A LIVE 0001731415 Keenan Capital Fund, LP 1229 BURLINGAME AVENUE SUITE 201 BURLINGAME CA CALIFORNIA 94010 6503443332 DELAWARE None None Limited Partnership true n/a n/a Keenan Capital GP, LLC 1229 Burlingame Avenue Suite 201 Burlingame CA CALIFORNIA 94010 Executive Officer General Partner of the Issuer Charles J Keenan IV 1229 Burlingame Avenue Suite 201 Burlingame CA CALIFORNIA 94010 Executive Officer Manager of the General Partner and Investment Adviser of the Issuer Alex n/a Prywes 1229 Burlingame Avenue Suite 201 Burlingame CA CALIFORNIA 94010 Executive Officer Chief Compliance Officer and Director of Operations of the Investment Adviser of the Issuer n/a n/a Keenan Capital, LLC 1229 Burlingame Avenue Suite 201 Burlingame CA CALIFORNIA 94010 Promoter Investment Adviser of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001731415-24-000002 2013-05-13 true true false 1000000 Indefinite 437670000 Indefinite false 58 0 0 0 false Keenan Capital Fund, LP Charles J Keenan IV Charles J Keenan IV Manager of the GP and Investment Adviser of the Issuer 2025-11-19